	Velesco Pharm, a development and clinical manufacturing company, has acquired a new facility in Wixom, MI, that expands and enhances its formulation and analytical R&D capabilities, the company announced on Oct. 23, 2018.

	The acquisition and fit-out of the new facility double the company’s formulation and analytical laboratory space. The increase in capacity expands its research and cGMP services, including formulation development, analytical method development/validation, release and stability testing, and cGMP clinical manufacturing. The move to the expanded facility will occur before the end of 2018.

	“Our new laboratory is impressively designed and equipped, and we will be increasing our scientific team such that we can meet our clients’ growing demand for pharmaceutical formulation and analytical services,” said Dave Barnes, PhD, CEO at Velesco, in a company press release.

Analytics

Deals, Development and Manufacturing

Facility Design and Engineering

Formulation

Laboratory Equipment and Instruments

Mergers and Acquisitions

PharmTech News

Supplier News

Pharmaceutical Technology\'s In the Lab eNewsletter-11-07-2018

he acquisition expands the company’s formulation and analytical R&D services.